Offers crystallographic and protein engineering technology, from cloning to structural determination, serving the biotechnology and pharmaceutical industry and the academic community. Located in San Diego, California.

Develops algorithmic based pattern recognition technologies as predictors for analyzing proteomic data. Profile of expertise and company in Philadelphia, Pennsylvania.

ProteoSep gel-free technology using LC-MS and other characterization techniques, for mapping intact proteins retained in the liquid phase for subsequent post translational modifications. Based in Darien, Illinois.

Company using developments in protein technologies to improve drug discovery and development process, providing synthetic proteins for pre-clinical testing. Includes glossary, overview of expertise, partnerships and careers available in Geneva, Switzerland.

Company inviting collaboration with biopharmaceutical companies on selected proteins, for mapping interactions, validating targets for drug screening for cancer, infectious and metabolic diseases, in Paris, France.

INCAPS offers research and technology validation featuring tools for experimental design, sample testing, technology validation, bio-statistical analysis and consulting from Indianapolis.

Company engaed in research and development of its own and in collaboration with partners, using expertise in identification and sequence characterisation of low expression proteins. Includes overview of facilities, corporate history and contacts in Rennes, France.

Indiana proteomics consortium developing novel instrumentation and analytical methods, to accelerate unmet medical intervention. Includes investor and partnering opportunities in Indianapolis.

LCI develops membrane for biochips to desalt contaminated samples, metal-chelating surface, immobilized streptavidin for the capture of biotinylated molecules, or other proteins or ligands for MALDI-MS. Basd in Fremont, California.

Pioneer in topological proteomics optimising the drug discovery, with proprietary technology for automated characterization at the single cell level, for preclinical and clinical research. Located in Magdeburg, Germany.

Drug discovery company that is focused on developing protein-based therapies to diseases where there is an unmet medical need, including reducing side effects. Corporate governance, prospectus, announcements, career opportunities and contacts in Subiaco, Western Australia.

Detecting, identifying and assaying protein biomarker patterns in blood, diagnosing and monitoring diseases, and predicting the efficacy of therapy, by analysis of using proprietary separation, detection and informatics. Includes employment opprotunities in South San Francisco, California.

Based on expertise since 1979, exploiting 2D-gel electrophoresis, mass spectrometry, molecular biology and bioinformatics for identifying and characterizing markers of disease, target proteins in drug screening and diagnostic tools in Odense, Denmark.

Offers array-based proteomic solutions for glycan analysis or glycoproteins and protein function assays, using proprietary tag technology to create related human proteins that retain their native bioactivity in the array format. Includes partnerships and profile of company in Maidenhead, England.

Mapping protein-protein interactions and identify new targets for drug discovery to treat cancer and cardiovascular disease. Explains technology platforms and aetology targeted, with FAQ, company alliances and management in Salt Lake City, Utah.

Offers fee-for-service in addition to utilizing their technology platform for in-house research, with E. coli clones to produce human recombinant proteins and libraries for data mining, with LIMS available to clients from Dortmund Germany.

Developing, production and commercialize biomarkers for fetal, maternal, pediatric and adult applications, focusing on early diagnosis of intra-amniotic infection during pregnancy. Includes key staff and facilities at OHSU and Portland, Oregon.

PRS offers protein separations and biological mass spectrometry. Includes protocols, publications, FAQ, training and consulting from Ann Arbor, Michigan.

Company concentrating on multidimensional proteome analysis for target identification and validation. Includes technology platform, diagnostic marker for Alzheimer, prostate and epithelial cancers, and careers at Mainz, Germany.

Introduction to technology and services based on photoaptamer array developing protein signature applications and instrument platforms, for the life sciences research and industry. Includes glossary, publication list and news from Boulder, Colorado.